- Investing Ideas
- /
- Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Grifols
Market Cap: €5.1b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF
€8.21
7D
11.2%
1Y
-7.0%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.5b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€49.50
7D
7.4%
1Y
-38.7%
Oryzon Genomics
Market Cap: €177.6m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.75
7D
2.8%
1Y
43.0%